Other
Tracheal Intubation
0
Pipeline Programs↗
7
Active Trials↗
1
Companies Involved↗
Tracheal Intubation is an early-stage landscape with 0 programs across 1 company. The most active players are Avera Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
35
clinical trials
Completed23 · 66%
Not yet recruiting4 · 11%
Unknown status4 · 11%
Recruiting2 · 6%
Terminated1 · 3%
Active, not recruiting1 · 3%
Clinical Trials
Trial Activity
35 trials
Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic Patients
Not yet recruiting·—·N/A·NCT07164326·100 enrolled
Effect of Nebulized Lignocaine on the Stress Response of Endotracheal Intubation in Pediatrics Undergoing Tonsillectomy Operation Monitored by Rise in Serum Cortisol Level Post Intubation
Not yet recruiting·—·N/A·NCT07139730·70 enrolled
Opioid-based Versus Opioid-free Endotracheal Intubation
Completed·—·N/A·NCT06464393·70 enrolled
Premedication for Non-Emergency Endotracheal Intubation In the NICU
Completed·—·Phase 4·NCT01749501·45 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)